Angene Chemical
Draw
|
Currency :
Home Products

AG003U0A

551-11-1 | Prostaglandin F2a

Chemical structure of Prostaglandin F2a, CAS 551-11-1
AG003U0A
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 551-11-1
Catalog Number AG003U0A(AGN-PC-0WAEXI)
Chemical Name Prostaglandin F2a
IUPAC Name (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid
InChI InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1
InChI Key PXGPLTODNUVGFL-YNNPMVKQSA-N
MDL Number MFCD00135231
Molecular Formula C20H34O5
Molecular Weight 354.4810
SMILES CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=CCCCC(O)=O
UNII B7IN85G1HY
Synonyms
9alpha,11beta PGF2, 9alpha,11beta-PGF2, alpha, PGF2, Dinoprost, Enzaprost F, Estrofan, F2 alpha, Prostaglandin, F2alpha, Prostaglandin, PGF2, PGF2 alpha, PGF2alpha, Prostaglandin F2, Prostaglandin F2 alpha, Prostaglandin F2alpha, dinoprost, prostaglandin F2alpha, PGF2alpha, Prostaglandin F2a, amoglandin, Enzaprost, Cerviprost, Enzaprost F, 551-11-1, panacelan, l-PGF2-alpha, Protamodin, l-Prostaglandin F2-alpha, Dinoprostum, Dinoprosta, Prostin F2alpha, cyclosin, Prostin F2-alpha, PGF-2alpha, PGF2 alpha, PGF2-alpha, Prostarmon F, Prostaglandin F2 alpha, Prostaglandin F2-alpha, 9alpha,11alpha-PGF2, PGF2, Prostaglandin F(sub 2a), Dinoprostum [INN-Latin], Dinoprosta [INN-Spanish], UNII-B7IN85G1HY, CCRIS 4253, U 14583, U-14583, Prostaglandin F2, HSDB 3315, Dinoprost [USAN:INN:BAN:JAN], CHEMBL815, BRN 2225571, B7IN85G1HY, CHEBI:15553, 9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid, Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,11alpha,13E,15S)-, (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid, NCGC00160385-01, 9alpha,11beta-PGF2, C20H34O5, (+-)-PGF2-alpha, 7-(3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-5-heptenoic acid, Prostaglandin F2|A, dl-Prostaglandin F2-alpha, (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-3,13-dien-1-oic acid, 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, l-, Prostaglandin F2alpha, dl-, 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, (1R-(1alpha(Z),2beta(S*,E),3alpha,5alpha))-, 9S,11R,15S-trihydroxy-5Z,13E-prostadienoic acid, (+)-Prostaglandin F2a, Prostin F 2 alpha, PGF2.alpha., (5Z,13E,15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dien-1-oic acid, 7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid, PGF2a, BRN 4153898, (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)cyclopentyl)hept-5-enoic acid, Prostaglandin F2.alpha., (+-)-PGF2alpha, 9a,11a-PGF2, SR-01000721847, (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid, PGF2-alpha racemic mixt., ( )-Prostaglandin F2alpha, (+)-Prostaglandin F2alpha, (5Z,9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid, 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, (+-)-, 5-HEPTENOIC ACID, 7-(3,5-DIHYDROXY-2-(3-HYDROXY-1-OCTENYL)CYCLOPENTYL)-, dl-, Prosmon (TN), Prostaglandin F2-alpha, racemic mixt., AC1NQWY5, DSSTox_CID_2946, DSSTox_RID_76800, DSSTox_GSID_22946, SCHEMBL24292, BSPBio_001494, BML1-F08, GTPL1884, Dinoprost (JP17/USAN/INN), 9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-oic acid, DTXSID9022946, PXGPLTODNUVGFL-YNNPMVKQSA-N, HMS1361K16, HMS1791K16, HMS1989K16, HMS2089F11, HMS3402K16, HMS3648N11, ZINC3830709, Tox21_111777, AN-796, BDBM50035622, CP0104, LMFA03010002, MFCD00135231, PDSP2_000079, AKOS030526160, CCG-208257, CS-4232, DB12789, IDI1_033964, NCGC00160385-02, NCGC00160385-04, NCGC00160385-05, NCGC00160385-06, 23518-25-4, CAS-551-11-1, HY-12956, LS-125835, P1885, Y0222, 62P015, C00639, D00081, SR-01000946457, SR-01000721847-2, SR-01000721847-4, SR-01000946457-1, U-14,583, (5Z,13E)-(15S)-9alpha,11alpha,15-Trihydroxyprosta-5,13-dienoate, (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoate, (5z,9alpha,11alpha,13e,15s)-9,11,15-trihydroxyprosta-5,13-dienoic acid, Prosta-10,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S), (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(E)-(3S)-3-hydroxy-1-octenyl}-cyclopentyl]-5-heptenoic acid, Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9-alpha,11-alpha,13E,15S)-(+-)- (9CI), Glandin, Estrofan, ProstaglandinF2a, Dinoprost trometamol, alpha, PGF2, dinoprost tromethamine, F2alpha, Prostaglandin, 9alpha,11beta PGF2, F2 alpha, Prostaglandin, PROSTAGLANDINF2ALPHA, D00HTY, Dinoprost/Prostaglandin F2a, FA(20:2(OH3,cyclo)), Dinoprost [USAN:BAN:INN:JAN], C20-H34-O5, CID5280363, 2039A, D015237, (5Z,9-alpha,11-alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid, Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)-, 38562-01-5, Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9-alpha,11-alpha,13E,15S)-(+)-, Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)-(.+.)-,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited